Aptos (APT) Jumps 5% as CEO Lands Congressional Spotlight

Washington comes knocking—and the market responds. Aptos CEO’s invitation to testify before U.S. Congress sends APT rallying 5%, proving once again that crypto prices thrive on regulatory theater.

When DC whispers ’oversight,’ traders hear ’buy signal.’ The Layer-1 token’s pop mirrors the sector’s Pavlovian response to political attention—never mind that actual legislation remains stuck in committee purgatory.

Another day, another crypto price movement divorced from fundamentals. But hey, at least this pump came with a side of legitimacy.

APT’s market cap stands at $3.1 billion. Its daily trading volume has climbed up along with its price, rising by 20.9% in the past 24 hours compared to the previous day.

According to the official site for the U.S. House Committee on Agriculture, Ching is one of four figures with prior knowledge and expertise on digital assets featured on the hearing’s witness list.

Aside from Ching, the other three witnesses invited to testify in front of Congress include Executive vice president of Milken Institute Finance and former U.S. SEC Commissioner Michael Piwowar, Partner at Willkie Farr & Gallagher LLP and former CFTC General Attorney Chelsea E. Pizzola, and Chair of Commodities Futures, and Derivatives Group and Co-Chair of Lowenstein crypto Ryne Miller.

Last April, the Aptos Foundation announced it has invested an undisclosed amount of funds into Universal Health Token or UHT. UHT is a Singaporean firm behind the Proof-of-Health protocol, which uses AI technology to make health tracking on the blockchain possible.

Within the same month, the U.S. SEC announced that it WOULD delay decisions on several crypto-based ETFs, putting dozens of applications on hold. Among the pending applications is Bitwise’s Aptos ETF application that was sent through on March 6.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.